Evidence map›Paper›PMID 35441580›Full record

ArticleBioengineered2022

Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor γ-mediated ferroptosis.

Xiao'e Fan, Manhong Xu, Qianfeng Ren, Yan Fan, Boshi Liu, Jiaqi Chen, Zhengmin Wang, Xiaoyan Sun

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Autophagy in ocular diseases: from mechanisms to therapeutic potential.Frontiers in cell and developmental biology · 2026
    Review
  10. Article
  11. Review
  12. Frontiers in oncology · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Metabolic Roles of Fatty Acid Binding Protein 4 (FABP4) in Fetal and Maternal Health and Maintenance of Pregnancy in Women with Obesity: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiao'e FanDepartment of Ophthalmology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
Manhong XuTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Qianfeng RenDepartment of Pathology, Jincheng People's Hospital, Shanxi Province, China.
Yan FanDepartment of Ophthalmology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
Boshi LiuTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Jiaqi ChenDepartment of Ophthalmology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
Zhengmin WangDepartment of Ophthalmology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
Xiaoyan SunDepartment of Ophthalmology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
Zoucheng People's Hospital · CNTianjin Medical University Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to explore the role of fatty acid binding protein 4 (FABP4) in diabetic retinopathy (DR), and to elucidate the potential regulatory mechanism. We firstly developed a mouse model of DR by injection with streptozocin (STZ) into C57BL/6 male mice and a cell model of DR by induction of high glucose (HG) to ARPE-19 cells. BMS309403, an inhibitor of FABP4, was employed for treatment. The blood glucose

Indexed as

Diabetes MellitusDiabetic RetinopathyFerroptosisAnimalsBlood GlucoseDown-RegulationFatty Acid-Binding ProteinsLipid PeroxidationMaleMiceMice, Inbred C57BLOxidative StressPPAR gammaBlood GlucoseFabp4 protein, mouseFatty Acid-Binding ProteinsPPAR gammadiabetic retinopathyFatty acid binding protein 4ferroptosislipid peroxidationoxidative stressperoxisome proliferator-activated receptor γ

Identifiers

PMID35441580
PMCPMC9161966
OpenAlexW4224244252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.